Process View
The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "plasminogen activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1.000 | ||
| PLAU | plasminogen activator, urokinase | 1.000 | Human | |
| PLAT | plasminogen activator, tissue | 1.000 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.990 | ||
| KNG1 | kininogen 1 | 0.720 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.678 | ||
| PLG | plasminogen | 0.627 | Human | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.538 | ||
| VTN | vitronectin | 0.513 | ||
| C1S | complement component 1, s subcomponent | 0.497 | ||
| ORM1 | orosomucoid 1 | 0.492 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.436 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.435 | ||
| C1R | complement component 1, r subcomponent | 0.401 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.391 | ||
| FN1 | fibronectin 1 | 0.375 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.346 | ||
| LPA | lipoprotein, Lp(a) | 0.214 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.183 | ||
| GAST | gastrin | 0.181 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.132 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.116 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.101 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.101 | ||
| NNMT | nicotinamide N-methyltransferase | 0.071 | ||
| SPHK1 | sphingosine kinase 1 | 0.067 | ||
| INHBA | inhibin, beta A | 0.061 | ||
| C3 | complement component 3 | 0.060 | ||
| ENG | endoglin | 0.059 | ||
| SAA4 | serum amyloid A4, constitutive | 0.057 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.054 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.050 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.045 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.044 | ||
| AEBP1 | AE binding protein 1 | 0.043 | ||
| EMP1 | epithelial membrane protein 1 | 0.037 | ||
| TNC | tenascin C | 0.036 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.031 | ||
| TTR | transthyretin | 0.031 | ||
| C8A | complement component 8, alpha polypeptide | 0.031 | ||
| F2 | coagulation factor II (thrombin) | 0.028 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.028 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.028 | ||
| TFR2 | transferrin receptor 2 | 0.027 | ||
| FGB | fibrinogen beta chain | 0.025 | ||
| F10 | coagulation factor X | 0.024 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.023 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.023 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.022 | ||
| EBP | emopamil binding protein (sterol isomerase) | 0.022 | ||
| LAMC3 | laminin, gamma 3 | 0.021 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.021 | ||
| OSMR | oncostatin M receptor | 0.021 | ||
| PIGR | polymeric immunoglobulin receptor | 0.020 | ||
| AMT | aminomethyltransferase | 0.020 | ||
| FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.020 | ||
| AFM | afamin | 0.019 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.019 | ||
| APOE | apolipoprotein E | 0.019 | ||
| RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.018 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.018 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.018 | ||
| GAS6 | growth arrest-specific 6 | 0.018 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.017 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.017 | ||
| C4BPB | complement component 4 binding protein, beta | 0.017 | ||
| NSDHL | NAD(P) dependent steroid dehydrogenase-like | 0.017 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.017 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.017 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.017 | ||
| FAP | fibroblast activation protein, alpha | 0.017 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.016 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.016 | ||
| XDH | xanthine dehydrogenase | 0.016 | ||
| ECM1 | extracellular matrix protein 1 | 0.016 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.016 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.016 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.016 | ||
| CP | ceruloplasmin (ferroxidase) | 0.016 | ||
| WFDC2 | WAP four-disulfide core domain 2 | 0.015 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.015 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.015 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.014 | ||
| IL8 | interleukin 8 | 0.014 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.014 | ||
| ARG1 | arginase, liver | 0.014 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.013 | ||
| APOA1 | apolipoprotein A-I | 0.013 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.013 | ||
| A2M | alpha-2-macroglobulin | 0.013 | ||
| C2 | complement component 2 | 0.013 | ||
| VEGFC | vascular endothelial growth factor C | 0.013 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.013 | ||
| FGG | fibrinogen gamma chain | 0.012 | ||
| TFF1 | trefoil factor 1 | 0.012 | ||
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.012 | ||
| FOSL1 | FOS-like antigen 1 | 0.012 | ||
| THY1 | Thy-1 cell surface antigen | 0.012 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.012 | ||
| RAB17 | RAB17, member RAS oncogene family | 0.012 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.012 | ||
| HRG | histidine-rich glycoprotein | 0.012 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.012 | ||
| SC4MOL | sterol-C4-methyl oxidase-like | 0.012 | ||
| PDPN | podoplanin | 0.012 | ||
| APOD | apolipoprotein D | 0.011 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.011 | ||
| HPX | hemopexin | 0.011 | ||
| LIPC | lipase, hepatic | 0.011 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.011 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.011 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.011 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.011 | ||
| PON3 | paraoxonase 3 | 0.011 | ||
| TMPRSS2 | transmembrane protease, serine 2 | 0.011 | Human | |
| PVR | poliovirus receptor | 0.011 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.011 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.011 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.010 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.010 |